摘要 ：3年4轮融资，这家公司深化AI与自动化研发，打造智慧实验室生态，助力生命科学数智化升级。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 近期，生命科学自动化领域领军企业——苏州中析生物信息有限公司（以下简称"中析生物"） 宣布完成由中金资本独家投资的数千万元A+轮融资。 本轮融资资金将主要用于深化中析生物核心的人工智能模型与算法研发，并升级其领先的自动 化工作站及仪器产品线，进一步推动智慧实验室的全面落地与持续优化。 值得关注的是，中析生物上一轮融资仅仅发生在半年前的2025年7月。从公司2023年至今的 4轮融资来看， 连续的资本认可，不仅是对中析生物过往成绩的肯定，更是对其所构建的"智 慧实验室"生态战略与商业模式的高度认同。 们的推送。 连续的融资成功， 根本原因在于中析生物独特的战略定位和清晰的商业化路径 。 首先，公司坚持" 人工智能+自动化设备+全程自主制造 "的发展模式，实现了从核心零部件到 整机组装的全链条闭环生产。这种深度垂直整合不仅保障了技术的领先性和系统的可靠性，也 构成了其核心竞争壁垒。 其次，中析生物正从单一的设备 ...

Core Viewpoint - The company, Maike Biological (300463.SZ), is advancing its Tianfu International Biological City IVD Industry Park project, which is currently in the specialized facility equipment validation, debugging, and calibration phase [1] Company Focus - The company is dedicated to in-depth development of clinical in vitro diagnostic platforms, emphasizing the importance of self-developed products [1] - The company is also promoting the development of smart laboratories as a core focus area [1]

Group 1 - The company is currently in the verification, debugging, and calibration phase for the Tianfu International Biocity IVD Industrial Park project [2] - The company focuses on in-depth development of various platforms for clinical in vitro diagnostics, emphasizing self-developed products [2] - The company is promoting the development of smart laboratories as a core initiative [2]